The emerging therapy of this peptide represents a exciting breakthrough in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide016902.activosblog.com/40543930/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment